Stocktoria
Zentalis Pharmaceuticals, Inc. ZNTL
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-04-03
Zentalis Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,818,546 | $19.7M | 6.7% |
| TWO SIGMA INVESTMENTS, LP | 2,956,526 | $6.9M | 4.11% |
| RENAISSANCE TECHNOLOGIES LLC | 1,938,145 | $4.5M | 2.7% |
| CITADEL ADVISORS LLC | 1,756,283 | $4.1M | 2.44% |
| D. E. Shaw & Co., Inc. | 1,484,098 | $3.5M | 2.07% |
| MILLENNIUM MANAGEMENT LLC | 1,289,822 | $3.0M | 1.79% |
| Point72 Asset Management, L.P. | 94,854 | $221,958 | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 22,675 | $53,059 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.